Feng Ren
Vorstandsvorsitzender bei Insilico Medicine Cayman TopCo
Aktive Positionen von Feng Ren
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 01.06.2021 | - |
| Vorstandsvorsitzender | 01.06.2022 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.02.2021 | - |
Karriereverlauf von Feng Ren
Ausbildung von Feng Ren
| University of Science & Technology of China | Undergraduate Degree |
| National University of Singapore | Graduate Degree |
| Harvard University | Doctorate Degree |
Statistik
International
| Cayman Islands | 2 |
| China | 2 |
| Singapur | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
